In vitro Coculture Assay to Assess Pathogen Induced Neutrophil Trans-epithelial Migration
January 6th, 2014
17.5K views
Neutrophil trans-epithelial migration in response to mucosal bacterial infection contributes to epithelial injury and clinical disease. An in vitro model has been developed that combines pathogen, human neutrophils, and polarized human epithelial cell layers grown on transwell filters to facilitate investigations towards unraveling the molecular mechanisms orchestrating this phenomenon.
Overview
This study investigates neutrophil trans-epithelial migration in response to mucosal bacterial infection, which contributes to epithelial injury and disease. An in vitro model combining human neutrophils and polarized epithelial cell layers is utilized to explore the underlying molecular mechanisms.
Key Study Components
Area of Science
- Neuroscience
- Immunology
- Cell Biology
Background
- Neutrophils play a critical role in the immune response to infections.
- Mucosal infections can lead to significant epithelial damage.
- Understanding neutrophil migration is essential for developing therapeutic strategies.
- In vitro models are crucial for studying complex biological interactions.
Purpose of Study
- To quantify neutrophil migration across epithelial monolayers.
- To assess the impact of bacterial infection on neutrophil behavior.
- To establish a reliable experimental model for future research.
Methods Used
- Collagen coating of transwells to support epithelial cell growth.
- Inverted transwell filter technique for cultivating epithelial monolayers.
- Infection of epithelial cells with cultured bacterial pathogens.
- Quantification of neutrophil migration using myeloperoxidase assays.
Main Results
- Significant increase in neutrophil migration observed in response to infection.
- Quantitative data supports the role of epithelial cells in neutrophil attraction.
- Visual demonstration of the method enhances accessibility for researchers.
- Findings contribute to understanding the dynamics of immune responses in mucosal tissues.
Conclusions
- The study provides insights into the mechanisms of neutrophil migration.
- Establishing this model can aid in future investigations of epithelial-neutrophil interactions.
- Results may inform therapeutic approaches to manage mucosal infections.
Frequently Asked Questions
What is the significance of neutrophil migration?
Neutrophil migration is crucial for the immune response, helping to clear infections and prevent tissue damage.
How does the in vitro model work?
The model uses transwell filters to grow epithelial monolayers and assess neutrophil migration in response to bacterial infection.
What methods are used to quantify neutrophil migration?
Myeloperoxidase assays are employed to quantify the number of neutrophils that migrate across the epithelial barrier.
Why is the inverted transwell filter technique important?
This technique allows for the cultivation of epithelial cells in a way that mimics natural conditions, enhancing the relevance of the findings.
What are the implications of this research?
Understanding neutrophil migration can lead to better therapeutic strategies for treating mucosal infections and related diseases.
Executive Industry Relevance
This in vitro coculture assay enables mechanistic interrogation of pathogen-induced neutrophil trans-epithelial migration, a key process in mucosal infectious and inflammatory diseases. By quantifying neutrophil movement across polarized epithelial barriers in response to infection, the model supports target validation and lead identification for therapies aimed at modulating neutrophilic infiltration. The assay provides predictive confidence in preclinical de-risking by linking epithelial infection to chemotactic neutrophil recruitment, informing go/no-go decisions in airway disease pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by testing how pathogenic infection drives neutrophil chemoattractant production and migration.
- Operational Value: Enables functional validation of targets involved in epithelial-neutrophil crosstalk using human-derived cells and clinically relevant pathogens.
- Predictive Value: Supports portfolio triage by quantifying neutrophil migration as a biomarker of inflammatory potential in mucosal tissues.
Screening & Assay Development
- Scientific Value: Delivers quantitative, myeloperoxidase-based readouts that enable dose-response analysis of compounds inhibiting neutrophil migration.
- Operational Value: Standardizes transwell-based epithelial barrier models with defined infection and neutrophil isolation protocols for reproducible screening.
- Scalability: Supports adaptation to other mucosal surfaces and pathogens, enabling platform reuse across infectious disease programs.
Translational & Preclinical Research
- Scientific Value: Models disease-relevant neutrophil migration in lung epithelium infected with P. aeruginosa, a key pathogen in cystic fibrosis and pneumonia.
- Operational Value: Provides a continuous workflow from epithelial culture to neutrophil quantification, enabling longitudinal assessment of migration dynamics.
- Risk Mitigation: Helps de-risk target selection by distinguishing pathogenic from non-pathogenic bacterial effects on neutrophil transmigration.
Pipeline & Workflow Integration
The assay fits within the discovery continuum from target validation through lead identification to preclinical efficacy testing, particularly for airway inflammatory diseases involving neutrophilic infiltration.
- Discovery Biology: Tests how apical epithelial infection with pathogens like PAO1 induces basolateral-to-apical neutrophil migration via endogenous chemoattractants.
- Screening: Enables compound screening by measuring reduced myeloperoxidase signal as an output of inhibited neutrophil migration across infected monolayers.
- Analytics: Uses myeloperoxidase activity as a quantitative, linear readout to correlate migrated neutrophil numbers with experimental conditions.
- Translational Research: Models human lung epithelial responses to P. aeruginosa, supporting relevance to cystic fibrosis and neutrophilic pneumonia.
- Enterprise Reuse: The collagen-coated transwell platform can be adapted to other epithelial-neutrophil systems, supporting cross-program standardization.
Operational & Enterprise Impact
- Scientific Value: Mechanistic de-risking of targets by clarifying the role of epithelial infection in driving neutrophil-mediated tissue injury.
- Operational Value: Standardized neutrophil isolation, bacterial culture, and transwell culture protocols improve reproducibility across teams.
- Strategic Value: Informs capital-efficient go/no-go decisions by quantifying neutrophilic migration as a surrogate for tissue-damaging inflammation.
- Portfolio Impact: Enables risk-adjusted prioritization of anti-inflammatory or anti-infective candidates based on migration inhibition efficacy.
Implementation Considerations
- Requires expertise in primary neutrophil isolation from human blood and sterile tissue culture techniques.
- Dependent on transwell systems, collagen coating equipment, and microplate readers for myeloperoxidase detection.
- Necessitates standardization of epithelial cell seeding, infection timing, and neutrophil addition timing across laboratories.
- Adaptation to alternative mucosal models (e.g., intestinal, nasal) may require optimization of epithelial cell sources and pathogen relevance.
- Limited by the 5-hour assay window and weekly epithelial culture timeline, which may affect high-throughput screening throughput.
Biopharma FAQs
Why does neutrophil migration quantification matter for target validation?
Quantifying neutrophil trans-epithelial migration provides a functional readout of epithelial-derived chemoattractant activity, enabling validation of targets involved in infection-induced inflammation. This measurement supports mechanistic de-risking by linking target modulation to reduced neutrophilic infiltration in mucosal tissues.
How does isolating the independent variable of epithelial infection improve discovery pipeline decisions?
By comparing neutrophil migration in response to pathogenic (PAO1) versus non-pathogenic (K12 E. coli) infection, the assay isolates epithelial infection as the independent variable driving chemoattractant production. This enables clear attribution of migration changes to pathogen-specific host responses, improving target confidence in antiviral or antibacterial programs.
What do quantitative myeloperoxidase measurements enable in assay interpretation?
Myeloperoxidase activity provides a linear, quantitative measure of migrated neutrophil numbers, allowing dose-response analysis and statistical comparison across conditions. This output supports go/no-go decisions by defining thresholds of neutrophilic migration associated with tissue-damaging potential.
Why are replication requirements important for cross-functional collaboration?
Replicate wells for negative (uninfected), positive (FMLP), and infection conditions ensure assay reliability and enable statistical validation of neutrophil migration differences. Consistent replication supports data sharing between discovery, preclinical, and translational teams by establishing assay robustness.
What statistical analysis capabilities are required before implementing this assay?
The assay requires capability to perform group comparisons (e.g., t-tests or ANOVA) across migration conditions using myeloperoxidase readouts to determine significant differences in neutrophil transmigration. Access to microplate reader data export and graphing tools is necessary for analyzing migration kinetics and compound effects.
Chapters in this video
0:05
Title
2:01
Collagen Coating Transwells
3:25
Seeding Collagen Coated Transwells with Epithelial Cells
4:30
Preparation of Epithelial Cell Layers for Migration Assay
6:01
Neutrophil Trans-epithelial Migration Assay
11:27
Results: Assessing Neutrophil Trans-epithelial Migration
13:23
Conclusion
